X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Pulmonary Therapy

期刊標題檢索 最新評論: 沒有評論


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Pulmonary Therapy]您好,您是該頁面的第 1602 位訪客。

期刊簡介
期刊名稱Pulmonary Therapy Pulmonary Therapy

(According to the latest JCR data, this journal is not indexed in the JCR.)
LetPub Score
3.9
50 ratings
Rate

Reputation
4.7

Influence
2.6

Speed
7.0

期刊簡稱
ISSN2364-1754
E-ISSN2364-1746
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.200.7040.982
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pulmonary and Respiratory Medicine
Q253 / 155
Category: Medicine
Subcategory: Respiratory Care
Q21 / 1

自引率 (2023-2024)4.30%自引率趨勢
掲載範囲
Aims and Scope



Pulmonary Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the use of pulmonary therapies, devices, and surgical techniques.



Areas of focus include, but are not limited to: asthma; chronic obstructive pulmonary disease; idiopathic pulmonary fibrosis; pulmonary hypertension; cystic fibrosis; lung cancer; respiratory tract disorders; allergic rhinitis and other respiratory allergies; influenza, pneumococcal infection, respiratory syncytial virus and other respiratory infections; and inhalers and other device therapies.



The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Pulmonary Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.



Rapid Publication



The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of pulmonary therapies.

Open Access

All articles published by Pulmonary Therapy are open access.

Personal Service



The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.



Digital Features and Plain Language Summaries



Pulmonary Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.



For examples of digital features please visit our showcase page https://springerhealthcare.com/expertise/publishing-digital-features/



Publication Fees



Upon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of €4500/ $5100/ £3650. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis.



Peer Review Process



Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.



At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials, and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor.



Preprints



We encourage posting of preprints of primary research manuscripts on preprint servers, authors’ or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals. Authors should disclose details of preprint posting during the submission process or at any other point during consideration in one of our journals. Once the manuscript is published, it is the author’s responsibility to ensure that the preprint record is updated with a publication reference, including the DOI and a URL link to the published version of the article on the journal website.

Please follow the link for further information on preprint sharing:

https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550



Copyright



Pulmonary Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.



Contact



For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.
官方網站https://www.springer.com/41030
在線稿件提交https://www.editorialmanager.com/puth/
開放訪問Yes
出版商Springer Nature
主題領域Medicine
出版國/地區United Kingdom
發行頻率年4回刊行
創刊年0
每年文章數29每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( GBP4700; USD6850; EUR5500; )
APC waiver:Check Notes
Other charges: No
Keywords: respiratory medicine、pulmonary medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
RESPIRATORY SYSTEMESCIQ250/100
索引 (SCI or SCIE)
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2364-1754%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 6 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Pulmonary Therapy】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PulmonologyH-index: 0

    CiteScore: 14.30
    European Respiratory ReviewH-index: 0

    CiteScore: 14.40
    ARCHIVOS DE BRONCONEUMOLOGIAH-index: 46

    CiteScore: 3.50
    Annals of the American Thoracic SocietyH-index: 0

    CiteScore: 10.00
    ERJ Open ResearchH-index: 0

    CiteScore: 6.20
    Seminars in Thoracic and Cardiovascular SurgeryH-index: 0

    CiteScore: 5.80
    Pulmonary CirculationH-index: 32

    CiteScore: 4.20
    Multidisciplinary Respiratory MedicineH-index: 18

    CiteScore: 4.40
    Journal of Clinical Tuberculosis and Other Mycobacterial DiseasesH-index: 0

    CiteScore: 4.00
    Current Sleep Medicine ReportsH-index: 0

    CiteScore: 2.50
    學科內最受檢索的期刊 頁面查看次數
    Pulmonary Circulation14028
    Annals of the American Thoracic Society12544
    Pulmonology11722
    European Respiratory Review10642
    ARCHIVOS DE BRONCONEUMOLOGIA10004
    General Thoracic and Cardiovascular Surgery9292
    Multidisciplinary Respiratory Medicine7126
    ERJ Open Research6417
    Seminars in Thoracic and Cardiovascular Surgery5047
    Chinese Journal of Lung Cancer1953
  •  

    Pulmonary Therapy Pulmonary Therapy
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    下一頁    末頁  (0/0)
  [Pulmonary Therapy] 的評論撰寫評論
暫無評論。
首頁    上一頁    下一頁    末頁  (0/0)

開始撰寫 [Pulmonary Therapy] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*